Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
24 January 2024, Israel: Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN.TASE:
Read More